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Rosaria Nardello1* , Vincenzo Antona1, Giuseppe Donato Mangano1, Vincenzo Salpietro2, 
Salvatore Mangano1 and Antonina Fontana1 
Abstract 
Background: Most studies relative to Y chromosome abnormalities are focused on the sexual developmental disor-
ders. Recently, a few studies suggest that some genes located on Y chromosome may be related to different neurode-
velopment disorders.
Case presentation: We report a child with sexual developmental disorder associated with a peculiar phenotype 
characterized by severe language impairment and autistic behaviour associated with a mosaicism [45,X(11)/46,XY(89)] 
and a partial deletion of the short and long arm of Y chromosome (del Yp11.31q11.23) that also involves the loss of 
both PCDH11Y and NLGN4Y genes. To our knowledge no study has ever reported the occurrence of the lack of both 
PCDH11Y and NLGN4Y located in the Y chromosome in the same patient.
Conclusions: We hypothesized a functional complementary role of PCDH11Y and NLGN4Y within formation/matu-
ration of the cerebral cortex. The impairment of early language development may be mainly related to the lack of 
PCDH11Y that underlies the early language network development and the later appearance of the autistic behaviour 
may be mainly related to deficit of inhibitory glicinergic neurotransmission NLGN4Y-linked.
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Background
Mixed gonadal dysgenesis 45,X/46,XY is a rare develop-
ment sex disorder (DSD) resulting from Y chromosome 
mosaicism, which induces abnormal gonadal develop-
ment characterized by a variable phenotype ranging 
from partial virilization and ambiguous genitalia to freely 
male or female phenotypes [1]. Although there is a clear 
physiological and behavioral difference between men and 
women, the studies regarding the cerebral dysfunctions 
mediated by the Y-linked genes have elicited less interest 
than those mediated by the X-linked genes which are 
more numerous and along known as related to mental 
functioning [2].
Recently, the role played by the Y chromosome in 
sexual development has been recognized in brain 
development too; the two X–Y homologous gene pair, 
PCDH11X/Y and NLGN4X/Y, are emerging as two 
important families of genes, protocadherins and neuroli-
gins, involved in neurodevelopmental disorders (schizo-
phrenia, autism, intellectual disability, and epilepsy) 
although the clinical evidence is still rare [3]. Both genes 
code for two distinct synaptic cell adhesion molecules 
that connect preand postsynaptic sites through homo or 
heterophilic interactions of their extracellular domains, 
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mediate trans-synaptic signaling cascades, and regulate 
multiple aspects of synapse development, function, and 
plasticity that are essential for the neurotransmission [4, 
5]. The main expression of both genes PCDH11Y and 
NLGN4Y in the brain and in the early stage of the devel-
opment suggested a link with the neurodevelopmental 
disorders that are more frequent in boys [6, 7]. As the 
clinical studies on the Y chromosome rearrangements are 
mainly directed towards the sexual development, here 
we present a child with mixed gonadal dysgenesis and a 
severe phenotype with developmental delay, language 
impairment, and autism spectrum disorder (ASD), recall-
ing a regressive subtype, associated with a mosaicism 
[45,X(11)/46,XY(89)] and partial deletion of the short 
and long arm of Y chromosome (del Yp11.31q11.23). The 
concurrent loss of both PCDH11Y and NLGN4Y genes, 
involved in the formation/maturation of the brain, has 
never been described before, to our knowledge.
Case presentation
The proband, a 30  months old child, is the only child 
born to healthy Italian unrelated parents. He was born 
at 40  weeks of gestation by normal vaginal delivery fol-
lowing a pregnancy complicated at the seventh month 
by two bleeding events. At birth the weight was 3950 g, 
the length was 50  cm, and the cranial circumference 
was 35.5 cm. The clinical postnatal course was unevent-
ful. From 9  months of age the child was patient of our 
Department for a developmental delay: he acquired the 
head control at 4 months of age, but he was still unable to 
sit. On neuropsychiatric examination the patient revealed 
hypotonia and dysmorphic features including frontal 
bossing, triangular facies, large pinnas, right cryptorchid-
ism and hypospadias. Abdominal ultrasound detected 
in the pelvic cavity a hypoechogenic areas of elongated 
shape consistent with a persistent Müllerian duct.
The echocardiogram revealed a patent foramen ovale. 
EEG showed a regular background activity and normal 
sleep patterns.
At 11  months the child was alert to his environment, 
interacted with the examiner and her mother through eye 
contact and vocalizations. He turned his head to sound, 
vocalized undifferentiated nasal sound and two differ-
ent vowel sounds; he smiled when the examiner smiled 
and vocalized when the examiner spoke. He transferred 
objects from hand to hand, but could not grasp them. He 
could roll over and twist his trunk, he could sit just for 
60  s. The child could not crawl and did not make early 
stepping movements. A formal development assessment 
by the Bayley Scales of Infant and Toddler Development—
Third Edition showed performance in the average range 
at the cognitive scale (PC 100). His general performance 
on language scale was below average range (86 PC), but 
receptive language skills were appropriate to age, and 
expressive language skills were impaired (scaled score 
respectively 10 and 5). On motor scale the performance 
was extremely low (PC 61). At 25 months of age the child 
showed an erratic response to name and did not react to 
sudden loud noises. He showed inconsistent eye contact 
and displayed negative affect in response to either the 
test material and the examiner or caregiver. He avoided 
all physical contact, did not attempt to engage in social 
interaction, rarely vocalized nasal and vowel sounds, but 
without intentional communication. He showed stereo-
typed fingertip movements (rubbing), repetitive objects 
manipulation (stack of blocks), and tendency to focus 
attention on stimuli for too long. He could walk, but did 
not run or walk up/down stairs. He grasped pencil with 
his fingertips and scribbled. His performance on the 
Bayley III were deteriorated. Composite score on Cogni-
tive and Language scales was 70 and 52 (below 2–3 sd) 
respectively. On Motor scale the performance was con-
sistently extremely low (PC 64). Child’s ability to engage 
in self-regulation of emotions and behaviors, and child’s 
social competence was extremely low (Socioemotional 
scale PC 70). At 29 months a semi-structured standard-
ized assessment of communication and social interaction 
(ADOS II toddler module) showed an overriding impair-
ment in social-emotional reciprocity, no initiation of 
social interaction and no sharing of emotions, along with 
reduced or absent imitation of others’ behavior, complete 
lack of speech, repetitive use of objects and reduced use 
of eye contact. The Comparison Score was 21 and indi-
cated a moderate to severe level of risk for ASD. A con-
ventional cytogenetic analysis, based on GTG-banded 
metaphases from peripheral blood lymphocytes of the 
patient at a 400-band resolution, revealed a mosaicism: 
45,X(11)/46,XY(89) and a partial deletion of the short 
and long arm of Y chromosome (del Yp11.31q11.23). 
ArrayCGH was performed using Human Genome CGH 
Microarray Kit (8 × 60  K) (Agilent Technologies, Santa 
Clara, CA, USA), according to the manufacturer’s rec-
ommendations. The aCGH analysis, using Agilent Cyto 
Genomic Analytics software (V.3.0.6.6) showed a de novo 
partial deletion of 26  Mb in the chromosome Y from 
position 2,656,461 (Yp11.31) to 28,504,079 (Yq11.23) 
according to UCSC Genome Browser (hg19;GRCh Build 
37, February 2009). The detailed data has been reported 
in “Additional file 1”.
Discussion and conclusions
In the last decade, it is emerging that neurodevelopmen-
tal disorders, including ID and ASD, are mainly caused 
by genetic factors. The new techniques of genetic analy-
sis, including chromosomal microarray and next-genera-
tion sequencing, have yield the identification of over 100 
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genes whose de novo postzygotic mutations, identified 
notably using the resequencing technologies, have sig-
nificantly contributed to identifying the origins of many 
clinical features within the neurodevelopmental disor-
ders [8]. A better understanding of the variants of uncer-
tain significance (VUS), of the intronic variants, and of 
mosaic mutations will further contribute to the identify-
ing of the genes responsible for the neurodevelopmental 
disorders [9].
Our patient with a karyotype 45,X/46,XY shows a 
clinical feature fulfilling the criteria of DSD identified as 
“congenital conditions in which development of chromo-
somal, gonadal, or anatomical sex is atypical” [1]. In addi-
tion, the proband has a gonadal dysgenesis, a well-known 
condition of an increased risk of malignant transforma-
tion; therefore, as also suggested by a recent investiga-
tion, he was at once referred within a specific surgical 
surveillance study [10]. In addition, he displays a severe 
phenotype characterized by language disorder, global 
developmental delay, poor social interaction, restricted 
interests, and repetitive and stereotyped behaviors with 
a peculiar clinical course that in some ways could evoke 
ASD subtype with regression of the main developmental 
functions. Most clinical studies regarding the 45,X/46,XY 
disorders, focused on the sexual development aspects. 
Recently, there is a growing evidence that some genes 
located on the Y chromosome are responsible for some 
neurodevelopmental disorders in addition to well-known 
DSD [3]. As our patient has an additional deletion of Y 
chromosome we tried to identify which role the lost 
genes could play in the cognitive and social develop-
ment. We think that within the set of lacking genes the 
PCDH11Y and NLGN4Y, despite the incomplete knowl-
edge of their molecular mechanisms, can play a signifi-
cant role in the mental dysfunction of our patient.
Protocadherins (PCDH)11 are cell adhesion mole-
cules belonging to the cadherin superfamily. Two types 
of PCDH11 were identified whose genes are located at 
Xq21.3 (PCDH11X) and at Yp11.2 (PCDH11Y) and share 
98.1% nucleotide and 98.3% amino acids [11].
PCDH11X/Y mRNA is expressed in many regions 
of the fetal and adult human brain, including fron-
tal, temporal, and occipital cortex, corpus callosum, 
amygdala, hippocampus, caudate nucleus, thalamus, 
substantia nigra, and cerebellum [4]. In addition, a lon-
gitudinal study of the prefrontal cortex using microarrays 
showed that levels of PCDH11Y change at different age, 
being highest in male neonates, and decrease through 
infancy and childhood [12]. The primary expression of 
PCDH11X/Y in the brain suggested a their significant 
role in the development and the functioning of the brain 
although many of their detailed molecular mechanisms 
are still unclear. Nevertheless, recent in vitro and in vivo 
studies documented that PCDH11X increased the neu-
ral proliferation, but decreased neural differentiation 
and premature migration, and that it exerted a negative 
regulator role of dendritic branching in cultured cortical 
neurons [13]. So, the PCDH11X/Y have been suggested 
as candidate genes for some neurodevelopmental disor-
ders though the clinical accumulated data supporting this 
view are yet very rare [3].
Genetic analysis of fourteen developmental dyslexic 
patients disclosed that five individuals had a duplication 
(ranging 113–166 Kb) and one patient a deletion of 2 Mb 
at Xq21.3 including PCDH11 gene [14].
In addition, it has been reported a male child with 
severe language delay, associated with a small deletion 
(Xq21.3 and Yp11.2) within the PCDH11X/Y gene. The X 
chromosome deletion was inherited from the unaffected 
carrier mother, but the Y chromosome deletion was a de 
novo occurrence [3].
This finding suggested that the PCDH11X/Y genes in 
humans play a role in language development and that 
rare copy number variation is a possible mechanism for 
communication disorders. Intriguingly, the deletion of 
Y chromosome of our patient extends to Yq11.23 region 
and includes the NLGN4Y, a family component of five 
postsynaptic cell-adhesion molecules (NL1, NL2, NL3, 
NL4 and NL4Y) that, interacting with the presynap-
tic neurexins, maintain trans-synaptic connection and 
function.
NLGN4 and NLGN4Y transcripts were detected in all 
male brain regions without significant differences in 
regional distribution syndrome [15]. It has been reported 
that in mice the neuroligin-4 mRNA levels increase from 
embryonic to postnatal phase with a plateau at 3 weeks 
[7, 15].
Functional analyses showed that the loss of neu-
roligin-4 caused a profound and selective reduction 
in glycinergic synaptic transmission, interacting with 
inhibitory postsynaptic gephyrin and collybistin proteins, 
without impairing excitatory synaptic transmission [7]. 
A clinical screening for mutations in NLGN4 in autistic 
individuals identified a frameshift NLGN4X mutation 
(1186insT) producing a stop codon at position 396 in 
two brothers of a Swedish family, one with typical autism 
and the other with Asperger syndrome [15]. Later, a 2-bp 
deletion in NLGN4X (1253delAG), leading to a prema-
ture stop codon encoding a truncating NLGN4X protein 
(D429X), was detected in 13 males from a French fam-
ily with intellectual disability, including two males with 
autism and one with pervasive developmental disorder 
[16].
Interestingly, a NLGN4Y missense variant, (c.2035A > G 
p.I679V), without any variant in the homologous 
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NLGN4X gene, was found in a patient with autism and in 
his father with learning disabilities [17].
Sadly, other studies did not disclose a high rate of 
NLGN4 mutations in autistic patients. Hence, it is likely 
that NLGN4 mutations may be responsible for a small 
subset of patients with autism, perhaps associated with 
a wider spectrum of neurodevelopmental disorders 
with mild to severe cognitive deficits.
The comparison of results of above mentioned stud-
ies suggests that the mutations of both PCDH11Y and 
NLGN4Y genes may be consistent with temporal pat-
terns of onset of the clinical feature of our patient.
Indeed, our subject revealed an early and persistent 
impairment of language development suggesting a 
detrimental influence of PCDH11Y on the basic pro-
cesses underlying the language maturation as above 
mentioned.
In addition, previous studies documented that the most 
inhibitory neurotransmission, mediated by GABAer-
gic and glycinergic synapses, during the first 2–3 weeks 
of rodent postnatal development shifts from immature 
depolarizing to mature hyperpolarizing functioning and 
from GABAergic to glycinergic transmission [18]. This 
temporal pattern of late maturation of glycinergic neu-
rotransmission seems to agree with the late appearance 
of autistic symptoms in our patient suggesting a pos-
sible relation between the lack of glycinergic inhibition 
NLGN4-modulated and the onset of autistic behavior. On 
the other hand, it has been reported that about one-third 
of ASD patients experienced a developmental regression 
between 15 and 24  months whose causal mechanism 
remains elusive although a genetic contribution includ-
ing genes coding for post synaptic density proteins, is 
recently emerging with strength [19]. In conclusion, our 
data cautiously suggest that both genes may play a com-
plementary functional role in the development of our 
patient’s disorder.
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